| pubmed-article:1708847 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1708847 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:1708847 | lifeskim:mentions | umls-concept:C0004398 | lld:lifeskim |
| pubmed-article:1708847 | lifeskim:mentions | umls-concept:C0038590 | lld:lifeskim |
| pubmed-article:1708847 | lifeskim:mentions | umls-concept:C0014298 | lld:lifeskim |
| pubmed-article:1708847 | lifeskim:mentions | umls-concept:C0013355 | lld:lifeskim |
| pubmed-article:1708847 | lifeskim:mentions | umls-concept:C0038585 | lld:lifeskim |
| pubmed-article:1708847 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
| pubmed-article:1708847 | pubmed:issue | 20 | lld:pubmed |
| pubmed-article:1708847 | pubmed:dateCreated | 1991-6-5 | lld:pubmed |
| pubmed-article:1708847 | pubmed:abstractText | Three peptide neuromodulators that are found in high concentration in the substantia nigra: dynorphin A 1-8, met5-enkephalin-arg6-gly7-leu8 and substance P, were measured by specific radioimmunoassays in nigral tissue from normals and schizophrenics postmortem. Substance P and dynorphin were unchanged between the two groups. However, the proenkephalin-derived peptide was significantly elevated in the schizophrenic group. The immunoreactivity was identified as authentic met5-enkephalin-arg6-gly7-leu8 by high pressure liquid chromatography. The data suggest that a different set of regulatory controls exists for nigral enkephalin peptides as compared to dynorphin and substance P, and that the former system may be disordered in schizophrenia. | lld:pubmed |
| pubmed-article:1708847 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1708847 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1708847 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1708847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1708847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1708847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1708847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1708847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1708847 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1708847 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1708847 | pubmed:issn | 0024-3205 | lld:pubmed |
| pubmed-article:1708847 | pubmed:author | pubmed-author:KleinmanJ EJE | lld:pubmed |
| pubmed-article:1708847 | pubmed:author | pubmed-author:IadarolaM JMJ | lld:pubmed |
| pubmed-article:1708847 | pubmed:author | pubmed-author:LingY CYC | lld:pubmed |
| pubmed-article:1708847 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1708847 | pubmed:volume | 48 | lld:pubmed |
| pubmed-article:1708847 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1708847 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1708847 | pubmed:pagination | 1919-30 | lld:pubmed |
| pubmed-article:1708847 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:meshHeading | pubmed-meshheading:1708847-... | lld:pubmed |
| pubmed-article:1708847 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1708847 | pubmed:articleTitle | Enkephalin, dynorphin and substance P in postmortem substantia nigra from normals and schizophrenic patients. | lld:pubmed |
| pubmed-article:1708847 | pubmed:affiliation | Neurobiology and Anesthesiology Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892. | lld:pubmed |
| pubmed-article:1708847 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1708847 | lld:pubmed |
